Cargando…
Commentary: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
Autores principales: | Seifirad, Soroush, Alquran, Lance |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7874198/ https://www.ncbi.nlm.nih.gov/pubmed/33585519 http://dx.doi.org/10.3389/fmed.2020.625440 |
Ejemplares similares
-
Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2020) -
Corrigendum: Antifibrotics in COVID-19 Lung Disease: Let Us Stay Focused
por: Chaudhary, Sachin, et al.
Publicado: (2021) -
The Elusive Antifibrotic Macrophage
por: Adhyatmika, Adhyatmika, et al.
Publicado: (2015) -
Pirfenidone: A novel hypothetical treatment for COVID-19
por: Seifirad, Soroush
Publicado: (2020) -
Commentary: Focus on the Gut–Kidney Axis in Health and Disease
por: Li, Yulu, et al.
Publicado: (2021)